NDC 59883-101 - ATRIDOX
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59883-101
- Package NDCs from labels
- 59883-101-01
- Manufacturer
- Den-Mat Holdings, LLC
- Effective date
- 2020-08-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ATRIDOX - Den-Mat Holdings, LLC | Den-Mat Holdings, LLC | 2020-08-25 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Hikma Pharmaceuticals USA Inc. | 4ec4c8ca-ce83-4948-8626-21eb82ae5c19 | 2025-10-28 | Warnings, Adverse reactions | 19XTS3T51U |
| DOXYCYCLINE | DOXYCYCLINE | Henry Schein, Inc | dd70368b-1949-4833-9d1e-f9f4cdacd9f3 | 2025-10-24 | Warnings, Adverse reactions | 19XTS3T51U |
| TARGADOX | DOXYCYCLINE HYCLATE | Journey Medical Corporation | 83243f78-b984-46a4-a88a-c6a15c217b90 | 2025-10-21 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline | DOXYCYCLINE HYCLATE | Cardinal Health 107, LLC | 53deb73a-c828-46e8-994e-d84e3bf8dc98 | 2025-10-02 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Ajanta Pharma USA Inc. | f18daceb-33a3-4931-9be7-ecd6356cc119 | 2025-10-01 | Warnings, Adverse reactions | 19XTS3T51U |
| DOXYCYCLINE DOXYCYCLINE | DOXYCYCLINE | Dr. Reddy's Laboratories, Inc. | c0206e91-d87f-311c-80dc-aad543d001e8 | 2025-10-01 | Warnings, Adverse reactions | 19XTS3T51U |
| doxycycline | DOXYCYCLINE | Chartwell Governmental & Specialty RX, LLC | b8486639-7eb9-4610-9cd4-0e922045d592 | 2025-09-30 | Warnings, Adverse reactions | 19XTS3T51U |
| doxycycline | DOXYCYCLINE | Chartwell RX LLC | 3e7cf78f-3b48-4614-9fa4-c6d1e0c05a35 | 2025-09-30 | Warnings, Adverse reactions | 19XTS3T51U |
| DOXYCYCLINE | DOXYCYCLINE | Piramal Critical Care Inc | fd672959-014f-8300-e053-6394a90a5ec5 | 2025-09-23 | Warnings, Adverse reactions | 19XTS3T51U |
| doxycycline hyclate | DOXYCLYCLINE HYCLATE | Lupin Pharmaceuticals, Inc. | f234f419-42da-4a6d-82c6-92106cd77c67 | 2025-09-19 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE | Amneal Pharmaceuticals NY LLC | 49ecbf95-58e8-4f3c-b5d5-650a15d866cb | 2025-09-17 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE | Amneal Pharmaceuticals NY LLC | 79f3c026-7687-4a11-8d2e-03493531d3bf | 2025-09-10 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline hyclate | DOXYCYCLINE HYCLATE | Viona Pharmaceuticals Inc | 51d245a3-ef51-474a-bc91-377d5f42dde3 | 2025-08-25 | Warnings, Adverse reactions | 19XTS3T51U |
| doxycycline hyclate | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Inc. | 131af052-0c4f-4a61-ae9a-e6165ae09076 | 2025-08-19 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Hikma Pharmaceuticals USA Inc. | 9b52e0a7-f024-4d8a-a59e-374946e60b44 | 2025-08-15 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Viona Pharmaceuticals Inc | 763997f0-b35c-43cb-a792-3e0bae589536 | 2025-08-12 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | JG Pharma Inc. | 10b8bf71-4311-41e8-a891-bab8bc86863f | 2025-08-01 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Larken Laboratories, Inc. | 49f82130-6f8a-412c-b625-e75906e74675 | 2025-07-31 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline hyclate | DOXYCYCLINE HYCLATE | Bryant Ranch Prepack | b612d2f5-b703-47f0-b5eb-b66a7aeed577 | 2025-06-27 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Actavis Pharma, Inc. | a569ba80-ffea-40b2-9fbe-a42810b1fccb | 2025-06-26 | Warnings, Adverse reactions | 19XTS3T51U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.